A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
NCT07060248 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2025-07-11
Summary
To evaluate the efficacy of CT-based radiomics in differentiating benign from malignant renal tumors, predicting nuclear grading of renal cell carcinoma, and assessing T-stage of renal tumors, thereby exploring its clinical application value.
Conditions
- Renal Cell Carcinoma (RCC)
Sponsors & Collaborators
-
Second Xiangya Hospital of Central South University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2027-06-30
- Completion
- 2027-06-30
Countries
- China
Study Locations
More Related Trials
-
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916 ·Status: RECRUITING
-
CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC
NCT04452058 ·Status: UNKNOWN
-
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach(Radiogenomics-Lung)
NCT06500312 ·Status: RECRUITING
-
Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning
NCT07332923 ·Status: ACTIVE_NOT_RECRUITING
-
A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer
NCT06405815 ·Status: COMPLETED
-
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
NCT07059923 ·Status: RECRUITING
-
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
NCT05925738 ·Status: UNKNOWN
-
Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma
NCT05736991 ·Status: UNKNOWN
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
NCT05214885 ·Status: RECRUITING
-
Radiomics Multifactorial Biomarker for Pulmonary Nodules
NCT03872362 ·Status: COMPLETED
-
Preliminary Study on Eye Features of Patients With Malignant Tumors
NCT04224298 ·Status: COMPLETED
-
Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer
NCT05252065 ·Status: UNKNOWN
-
Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter Study
NCT06356441 ·Status: NOT_YET_RECRUITING
-
Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
NCT05185544 ·Status: UNKNOWN
-
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
NCT00718367 ·Status: COMPLETED
-
Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma
NCT06111560 ·Status: COMPLETED
-
Clinicopathological Features of Renal Cell Carcinoma in Young Patients
NCT06730997 ·Status: NOT_YET_RECRUITING
-
Classification of Benign and Malignant Lung Nodules Based on CT Raw Data
NCT04241614 ·Status: COMPLETED
-
Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
NCT06831357 ·Status: RECRUITING
-
The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models
NCT06768853 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
NCT07027280 ·Status: RECRUITING
-
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
NCT05782400 ·Status: ACTIVE_NOT_RECRUITING
-
AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma
NCT06463756 ·Status: RECRUITING
-
DNA Methylation Combined With Artificial Intelligence Imaging to Identify Lung Nodules
NCT06220305 ·Status: RECRUITING